Wall Street Journal knocks Trump on expanding drug price controls: 'Worst idea since tariffs'

The editorial board of the Wall Street Journal is criticizing President Trump over an executive order expanding drug price controls. "For that trade we could have elected Democrats," the right-leaning Journal board wrote. "Trying to wring more money out of drug makers might cause some companies to stop participating in Medicaid." "Patients would then suffer...